NovaBay Pharmaceuticals, Inc. Logo

NovaBay Pharmaceuticals, Inc.

Develops and commercializes eyecare, skincare, and wound care products.

NBY | US

Overview

Corporate Details

ISIN(s):
US66987P2011
LEI:
Country:
United States of America
Address:
2000 POWELL STREET, SUITE 1150, 94608 EMERYVILLE

Description

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company that develops and commercializes scientifically-created and clinically-proven products for the eyecare, skincare, and wound care markets. The company's core technology is a proprietary, stable formulation of hypochlorous acid. Its leading product is Avenova®, an antimicrobial lid and lash solution available over-the-counter for eye hygiene. In the wound care sector, NovaBay manufactures and sells products under the NeutroPhase® and PhaseOne® brands, which utilize its hypochlorous acid technology to aid in cleansing and debridement. The company focuses on providing accessible, problem-solving solutions for improved well-being.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all NovaBay Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NovaBay Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NovaBay Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Eutilex Co.,Ltd. Logo
Develops immunotherapeutics for cancers and autoimmune diseases via T-cell/antibody tech.
South Korea
263050
Evoke Pharma Inc Logo
A specialty pharma company developing drugs for gastrointestinal (GI) diseases.
United States of America
EVOK
Evolus, Inc. Logo
A performance beauty company developing neurotoxins and dermal fillers.
United States of America
EOLS
EXACT Therapeutics AS Logo
Clinical-stage biopharma using ultrasound to amplify the effect of co-administered drugs.
Norway
EXTX
EXELIXIS, INC. Logo
Oncology-focused biotech that discovers, develops, and commercializes cancer therapies.
United States of America
EXEL
ExpreS2ion Biotech Holding AB Logo
A clinical-stage biotech company developing vaccines for cancer and infectious diseases.
Sweden
EXPRS2
EyePoint Pharmaceuticals, Inc. Logo
Develops sustained drug delivery therapeutics for serious retinal diseases.
United States of America
EYPT
Faes Farma S.A. Logo
Researches, develops, and markets pharmaceuticals and animal nutrition products.
Spain
FAE
Fagron N.V. Logo
A global pharmaceutical compounding company focused on personalized medicine.
Belgium
FAGR
Farmak Logo
Researches, develops, and manufactures medicines for distribution in over 60 countries.
Ukraine
FARM

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.